A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults

Conditions:   Severe Acute Respiratory Syndrome;   Coronavirus;   SARS-CoV-2;   COVID-19 Interventions:   Biological: CVnCoV Vaccine;   Drug: Placebo Sponsors:   CureVac AG;   Coalition for Epidemic Preparedness Innovations (CEPI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials